CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated

被引:8
|
作者
Pike, Sarah [1 ,2 ]
Peng, Chen-Ching [1 ]
Neviani, Paolo [3 ]
Berry, Jesse L. [1 ,2 ,4 ,5 ,7 ,8 ]
Xu, Liya [1 ,2 ,4 ,6 ]
机构
[1] Childrens Hosp Los Angeles, Vis Ctr, Los Angeles, CA USA
[2] Univ Southern Calif, USC Roski Eye Inst, Keck Sch Med, Los Angeles, CA USA
[3] Childrens Hosp Los Angeles, Extracellular Vesicle Core, Los Angeles, CA USA
[4] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA USA
[5] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA USA
[6] Childrens Hosp Los Angeles, Res Ophthalmol, 4650 Sunset Blvd, Los Angeles, CA 90027 USA
[7] Childrens Hosp Los Angeles, Dept Surg, 4650 Sunset Blvd, Los Angeles, CA 90027 USA
[8] Childrens Hosp Los Angeles, Ocular Oncol, 4650 Sunset Blvd, Los Angeles, CA 90027 USA
关键词
extracellular vesicles (EVs); retinoblastoma; aqueous humor (AH); liquid biopsy; FINE-NEEDLE-ASPIRATION; BIOPSY; EXOSOMES; CANCER; OUTCOMES; DISEASE;
D O I
10.1167/iovs.64.10.5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Although biopsy is contraindicated in retinoblastoma (RB), the aqueous humor (AH) is a robust liquid biopsy source of molecular tumor information, facilitating biomarker discovery. Small extracellular vesicles (sEVs), promising biomarker candidates across multiple cancers, were recently identified in RB AH, but relationships between sEVs and RB clinical features are unknown.METHODS. We analyzed sEVs in 37 AH samples from 18 RB eyes of varying International Intraocular Retinoblastoma Classification (IIRC) groups and explored clinical correlations. Ten samples were collected at diagnosis (DX) and 27 during treatment (Tx). Unprocessed AH underwent Single Particle-Interferometric Reflectance Imaging Sensor (SP-IRIS) analysis for fluorescent particle count and tetraspanin immunophenotyping; counts were subsequentially converted to percentages for analysis.RESULTS. Comparing DX and Tx samples, a higher percentage of CD63/81+ sEVs was found in DX AH (16.3 & PLUSMN; 11.6% vs. 5.49 & PLUSMN; 3.67% P = 0.0009), with a more homogenous mono-CD63+ sEV population seen in Tx AH (43.5 & PLUSMN; 14.7% vs. 28.8 & PLUSMN; 9.38%, P = 0.0073). Among DX samples, CD63/81+ sEVs were most abundant in group E eyes (n = 2) compared to group D (n = 6) by count (2.75 x 105 & PLUSMN; 3.40 x 105 vs. 5.95 x 103 & PLUSMN; 8.16 x 103, P = 0.0006), and to group A + B (n = 2) by count (2.75 x 105 & PLUSMN; 3.40 x 105 vs. 2.73 x 102 & PLUSMN; 2.59 x 102, P = 0.0096) and percentage (32.1 & PLUSMN; 7.98% vs. 7.79 & PLUSMN; 0.02%, P = 0.0187).CONCLUSIONS. CD63/81+ sEVs enrich AH from RB eyes before treatment and those with more significant tumor burden, suggesting they are tumor-derived. Future research into their cargo may reveal mechanisms of cellular communication via sEVs in RB and novel biomarkers.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Protein kinase activity is associated with CD63 in melanoma cells
    Iida, J
    Skubitz, APN
    McCarthy, JB
    Skubitz, KM
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [22] CD63-Snorkel tagging for isolation of tissue-specific small extracellular vesicles
    Qin, Gangjian
    Han, Chaoshan
    PHYSIOLOGY, 2023, 38
  • [23] Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells
    Parthasarathy, Varadarajan
    Martin, Francine
    Higginbottom, Adrian
    Murray, Helen
    Moseley, Gregory W.
    Read, Robert C.
    Mal, Gorakh
    Hulme, Rachel
    Monk, Peter N.
    Partridge, Lynda J.
    IMMUNOLOGY, 2009, 127 (02) : 237 - 248
  • [24] The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients
    Paolino, Giovanni
    Huber, Veronica
    Camerini, Serena
    Casella, Marialuisa
    Macone, Alberto
    Bertuccini, Lucia
    Iosi, Francesca
    Moliterni, Elisa
    Cecchetti, Serena
    Ruspantini, Irene
    Chiarotti, Flavia
    Vergani, Elisabetta
    Lalli, Luca
    Raggi, Carla
    Di Biase, Antonella
    Calvieri, Stefano
    Mercuri, Santo Raffaele
    Lugini, Luana
    Federici, Cristina
    CANCERS, 2021, 13 (16)
  • [25] The Aging Process Alters IL-1β and CD63 Levels Differently in Extracellular Vesicles Obtained from the Plasma and Cerebrospinal Fluid
    de Andrade, Gisele Gomes
    Cechinel, Laura Reck
    Bertoldi, Karine
    Galvao, Fernando
    Worm, Paulo Valdeci
    Siqueira, Ionara Rodrigues
    NEUROIMMUNOMODULATION, 2018, 25 (01) : 18 - 22
  • [26] An anion exchange membrane sensor detects EGFR and its activity state in plasma CD63 extracellular vesicles from patients with glioblastoma
    Maniya, Nalin H.
    Kumar, Sonu
    Franklin, Jeffrey L.
    Higginbotham, James N.
    Scott, Andrew M.
    Gan, Hui K.
    Coffey, Robert J.
    Senapati, Satyajyoti
    Chang, Hsueh-Chia
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [27] Disuse Atrophy Elevates Skeletal Muscle CD63 Expression and Ex Vivo Release of Extracellular Vesicles in a Muscle-Specific Manner
    Van Pelt, Douglas
    Butterfield, Timothy
    Dupont-Versteegden, Esther
    FASEB JOURNAL, 2021, 35
  • [28] Parallel SPR and QCM-D Quantitative Analysis of CD9, CD63, and CD81 Tetraspanins: A Simple and Sensitive Way to Determine the Concentration of Extracellular Vesicles Isolated from Human Lung Cancer Cells
    Kowalczyk, Agata
    Gajda-Walczak, Aleksandra
    Ruzycka-Ayoush, Monika
    Targonska, Alicja
    Mosieniak, Grazyna
    Glogowski, Maciej
    Szumera-Cieckiewicz, Anna
    Prochorec-Sobieszek, Monika
    Bamburowicz-Klimkowska, Magdalena
    Nowicka, Anna M.
    Grudzinski, Ireneusz P.
    ANALYTICAL CHEMISTRY, 2023, 95 (25) : 9520 - 9530
  • [29] Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process
    Tognoli, Maria Laura
    Dancourt, Julia
    Bonsergent, Emeline
    Palmulli, Roberta
    de Jong, Olivier G.
    Van Niel, Guillaume
    Rubinstein, Eric
    Vader, Pieter
    Lavieu, Gregory
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [30] Clinicopathological features associated with CD44 and CD63 expression in breast cancer
    Castaneda, Carlos A.
    Castillo, Miluska
    Sanchez, Joselyn
    Bernabe, Luis
    Tello, Katherin
    Suarez, Nancy
    Alatrista, Raul
    Quiroz-Gil, Ximena
    Granda-Oblitas, Alexandra
    Enciso-Benavides, Javier
    Enciso, Nathaly
    Gomez, Henry L.
    ECANCERMEDICALSCIENCE, 2024, 18